Intermune gets major setback for lung treatment – InterMune took its best case for pirfenidone to the FDA, and lost. The agency ruled Tuesday afternoon that the developer would need to mount a new clinical trial for the drug before it could provide a green light for marketing…more
Outsourced Training – Sometimes, you don’t have the staffing to meet all the training needs (short-term or long-term). We can help. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
Moving Beyond Blue – my review of a book by an individual struggling with depression, OCD, anxiety, and more.
JUST FOR FUN
Gorgeous pictures of railway bridges. Lots of ’em!
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board